Table 3 Means and standard deviations of outcome measures of all participants at baseline, 3, 6 and 12 months’ follow-up measures

HBI

Group 1

3.30

3.2

10

5.50

6.05

8

11.20

5.45

5

8.00

2.45

5

Group 2

4.33

2.74

9

5.50

4.46

6

7.80

3.70

5

5.00

0.00

3

SCCAI

Group 1

5.22

3.22

3

4.00

2.83

2

7

0

1

11.00

4.24

2

Group 2

4.50

2.52

4

4.50

1.22

6

8.67

1.16

3

7.50

0.71

2

IBD-F1

Group 1

11.93

3.24

14

8.00

4.61

9

7.83

3.66

6

8.43

2.51

7

Group 2

9.93

4.13

15

9.45

4.97

11

8.13

4.16

8

8.00

2.65

5

IBD-F2

Group 1

55.83

26.74

12

23.40

15.09

10

31.75

25.86

6

29.85

18.89

7

Group 2

49.00

28.66

15

44.20

30.96

10

23.49

25.33

8

21.05

12.66

5

IBDQ

Group 1

89.67

13.67

15

97.50

11.20

10

91.83

18.70

6

97.57

8.89

7

Group 2

93.79

8.87

14

95.27

10.10

11

100.88

10.86

8

100.00

4.30

5

BIPQ

Group 1

41.13

6.20

15

32.40

6.83

10

Group 2

42.40

7.14

15

43.20

6.14

10

ESS

Group 1

13.87

4.85

15

7.00

4.42

10

Group 2

10.19

4.69

16

9.82

3.90

11

GAD7

Group 1

9.80

5.54

15

4.50

3.53

10

Group 2

8.00

5.27

16

5.00

3.52

11

PHQ9

Group 1

12.00

6.01

15

6.00

4.42

10

Group 2

9.75

6.00

16

8.73

4.71

11